These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39418930)

  • 41. Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice.
    Marrero-Rosado BM; de Araujo Furtado M; Kundrick ER; Walker KA; Stone MF; Schultz CR; Nguyen DA; Lumley LA
    Epilepsy Behav; 2020 Oct; 111():107229. PubMed ID: 32575012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
    Niquet J; Baldwin R; Norman K; Suchomelova L; Lumley L; Wasterlain CG
    Epilepsia; 2016 Sep; 57(9):1406-15. PubMed ID: 27500978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review.
    Golub D; Yanai A; Darzi K; Papadopoulos J; Kaufman B
    Anaesth Intensive Care; 2018 Sep; 46(5):516-528. PubMed ID: 30189827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
    Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
    Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketamine to treat super-refractory status epilepticus.
    Alkhachroum A; Der-Nigoghossian CA; Mathews E; Massad N; Letchinger R; Doyle K; Chiu WT; Kromm J; Rubinos C; Velazquez A; Roh D; Agarwal S; Park S; Connolly ES; Claassen J
    Neurology; 2020 Oct; 95(16):e2286-e2294. PubMed ID: 32873691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice.
    Dhote F; Carpentier P; Barbier L; Peinnequin A; Baille V; Pernot F; Testylier G; Beaup C; Foquin A; Dorandeu F
    Toxicol Appl Pharmacol; 2012 Mar; 259(2):195-209. PubMed ID: 22245128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketamine successfully terminates malignant status epilepticus.
    Prüss H; Holtkamp M
    Epilepsy Res; 2008 Dec; 82(2-3):219-22. PubMed ID: 18804344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series.
    DeVine MN; Gordon SE; Press CA
    J Pediatr Pharmacol Ther; 2023; 28(2):161-166. PubMed ID: 37139250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies*.
    Wilkes R; Tasker RC
    Pediatr Crit Care Med; 2014 Sep; 15(7):632-9. PubMed ID: 24901802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of neuroprotective treatment efficiency using a HRMAS NMR-based statistical model of refractory status epilepticus on mouse: a metabolomic approach supported by histology.
    Fauvelle F; Carpentier P; Dorandeu F; Foquin A; Testylier G
    J Proteome Res; 2012 Jul; 11(7):3782-95. PubMed ID: 22621346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric refractory and super-refractory status epilepticus.
    Vasquez A; Farias-Moeller R; Tatum W
    Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of Refractory Status Epilepticus With Continuous Intravenous Anesthetic Drugs: A Systematic Review.
    Au YK; Kananeh MF; Rahangdale R; Moore TE; Panza GA; Gaspard N; Hirsch LJ; Fernandez A; Shah SO
    JAMA Neurol; 2024 May; 81(5):534-548. PubMed ID: 38466294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
    Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
    J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus.
    Sabharwal V; Ramsay E; Martinez R; Shumate R; Khan F; Dave H; Iwuchukwu I; McGrade H
    Epilepsy Behav; 2015 Nov; 52(Pt A):264-6. PubMed ID: 26523340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative non-randomized study with midazolam versus thiopental in children with refractory status epilepticus].
    Löhr A; Werneck LC
    Arq Neuropsiquiatr; 2000 Jun; 58(2A):282-7. PubMed ID: 10849628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
    Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E
    Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.
    Alvarez V; Lee JW; Drislane FW; Westover MB; Novy J; Dworetzky BA; Rossetti AO
    Epilepsia; 2015 Aug; 56(8):1275-85. PubMed ID: 26140660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.
    Gaspard N; Foreman B; Judd LM; Brenton JN; Nathan BR; McCoy BM; Al-Otaibi A; Kilbride R; Fernández IS; Mendoza L; Samuel S; Zakaria A; Kalamangalam GP; Legros B; Szaflarski JP; Loddenkemper T; Hahn CD; Goodkin HP; Claassen J; Hirsch LJ; Laroche SM
    Epilepsia; 2013 Aug; 54(8):1498-503. PubMed ID: 23758557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.